Purdue Pharma reaches new $5.5bn-$6bn settlement in bankruptcy case
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Purdue Pharma reaches new $5.5bn-$6bn settlement in bankruptcy case

Prescription drug pill bottle oxycodene.jpg

Purdue Pharma has reached a new settlement with the nine states opposing its latest Chapter 11 plan that would raise the Sackler family’s contributions to as much as $6bn.

The new settlement comes after the court last month ordered the nine states and the Sackler family mediation parties back to negotiations around the proposed Chapter 11 plan, which had faced objections, according to court documents reviewed by Inside...

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Gift this article